2/3
Health Sciences
FDA approves ‘glowing tumor’ imaging drug to aid lung cancer surgery
FDA approves ‘glowing tumor’ imaging drug to aid lung cancer surgery
The injectable diagnostic, Cytalux, binds to cancerous tissue and glows, making it easier for surgeons to remove tumors completely while sparing healthy tissue.
Advances in cancer research
Advances in cancer research
Recent research shows promise in a novel CAR T therapy after cancer relapse, and a novel treatment for multiple myeloma.
How the perception of risks and benefits influence cancer clinical trial withdrawal outcomes
How the perception of risks and benefits influence cancer clinical trial withdrawal outcomes
A new study from the School of Nursing examines the association between patients’ perceived benefits and burdens of research participation and withdrawal.
A gateway from high school to Penn Medicine
A gateway from high school to Penn Medicine
Penn Medicine’s Pathways Emerging Careers Program invites Philadelphia high school graduates to start a career with Penn Medicine with extra coaching, training, and mentoring.
A target for improving recovery from lung injury
A target for improving recovery from lung injury
After a bout of severe respiratory disease, some patients never fully recover. New research from the School of Veterinary Medicine identifies a factor responsible for inappropriate tissue regrowth after infection, pointing to a possible therapeutic target.
At Engaging Minds, three Penn Integrates Knowledge Professors take the stage
Alumni heard Lance Freeman examine racial equity in city planning, Dolores Albarracín talk about how conspiracy theories take hold, and Kevin Johnson discuss the importance of clear science communication.
Study shows promise of new anti-KRAS drug for pancreatic cancer
Study shows promise of new anti-KRAS drug for pancreatic cancer
A small molecule inhibitor that attacks the difficult cancer-causing gene mutation KRAS successfully shrunk tumors or stopped cancer growth in preclinical models of pancreatic cancer.
Two from Penn named Distinguished Members of the Association for Computing Machinery
Two from Penn named Distinguished Members of the Association for Computing Machinery
Jing (Jane) Li of the School of Engineering and Applied Science and Li Shen of the Perelman School of Medicine have been named distinguished members of the Association for Computing Machinery.
How ketamine acts as ‘switch’ in the brain
How ketamine acts as ‘switch’ in the brain
Penn researchers find that the anesthetic and fast-acting antidepressant switches natural patterns of neuronal activity in the cerebral cortex.
For ‘spirit of innovation,’ three from Penn named National Academy of Inventors Fellows
For ‘spirit of innovation,’ three from Penn named National Academy of Inventors Fellows
Vijay Kumar of the School of Engineering and Applied Science and Katalin Karikó and Drew Weissman of the Perelman School of Medicine were honored with the recognition.
In the News
The Hill
Virology is part of the golden age of health: Don’t dismantle it
James Alwine of the Perelman School of Medicine co-writes that over-regulation could unduly constrain the ability to respond to future viral pandemic threats.
FULL STORY →
Lancaster Farming
Coryza, an avian influenza lookalike, lingers in Lancaster
Sherrill Davison of the School of Veterinary Medicine outlines the symptoms and signs of infectious coryza, an avian influenza lookalike.
FULL STORY →
ANI News (India)
University of Pennsylvania pledges to bolster relations with India at "Penn India Engagement Forum"
PIK Professor Ezekiel J. Emanuel, Dean Erika H. James of the Wharton School, and Dean Vijay Kumar of the School of Engineering and Applied Science are quoted on the forum to support India's exceptional growth and specific health care needs.
FULL STORY →
The New York Times
‘We need pleasure to survive’
PIK Professor Ezekiel J. Emanuel says that moderation is a good principle and comments on whether tweaks in bad behavior can help. The work of Adam Grant is suggested for additional reading and an understanding of "languishing."
FULL STORY →
Nature
The race to supercharge cancer-fighting T cells
Carl June and Avery Posey of the Perelman School of Medicine discuss the progression and expansion of CAR-T cell therapies.
FULL STORY →